Literature DB >> 28432450

Genetic aberrations and molecular biology of skull base chordoma and chondrosarcoma.

Yohei Kitamura1, Hikaru Sasaki2, Kazunari Yoshida2.   

Abstract

Chordomas and chondrosarcomas are two major malignant bone neoplasms located at the skull base. These tumors are rarely metastatic, but can be locally invasive and resistant to conventional chemotherapies and radiotherapies. Accordingly, therapeutic approaches for the treatment of these tumors can be difficult. Additionally, their location at the skull base makes them problematic. Although accurate diagnosis of these tumors is important because of their distinct prognoses, distinguishing between these tumor types is difficult due to overlapping radiological and histopathological findings. However, recent accumulation of molecular and genetic studies, including extracranial location analysis, has provided us clues for accurate diagnosis. In this report, we review the genetic aberrations and molecular biology of these two tumor types. Among the abundant genetic features of these tumors, brachyury immunohistochemistry and direct sequencing of IDH1/2 are simple and useful techniques that can be used to distinguish between these tumors. Although it is still unclear why these tumors, which have such distinct genetic backgrounds, show similar histopathological findings, comparison of their genetic backgrounds could provide essential information.

Entities:  

Keywords:  Chondrosarcoma; Chordoma; Genetics; Skull base

Mesh:

Substances:

Year:  2017        PMID: 28432450     DOI: 10.1007/s10014-017-0283-y

Source DB:  PubMed          Journal:  Brain Tumor Pathol        ISSN: 1433-7398            Impact factor:   3.154


  5 in total

Review 1.  Advances in the management of primary bone sarcomas of the skull base.

Authors:  Idara Edem; Franco DeMonte; Shaan M Raza
Journal:  J Neurooncol       Date:  2020-04-18       Impact factor: 4.130

2.  Advancement of PI3 Kinase Inhibitor Combination Therapies for PI3K-Aberrant Chordoma.

Authors:  Molly E Heft Neal; Nicole L Michmerhuizen; Kevin J Kovatch; John Henry J Owen; Jingyi Zhai; Hui Jiang; Erin L McKean; Mark E P Prince; J Chad Brenner
Journal:  J Neurol Surg B Skull Base       Date:  2020-10-12

3.  Genetic landscape and ligand-dependent activation of sonic hedgehog-Gli1 signaling in chordomas: a novel therapeutic target.

Authors:  Chenlong Yang; Lei Yong; Chen Liang; Yan Li; Yunlong Ma; Feng Wei; Liang Jiang; Hua Zhou; Guanping He; Xiaoyu Pan; Bao Hai; Jian Wu; Yulun Xu; Zhongjun Liu; Xiaoguang Liu
Journal:  Oncogene       Date:  2020-05-14       Impact factor: 9.867

4.  Low-Grade Chondrosarcoma In The Sellar Area: Case Report And Literature Review.

Authors:  Zhen Zhang; Li-Juan Pang; Ning Wang; Zhong Li; Yu-Wen Cao; Wen-Hao Hu; Wei-Hua Liang; Jin-Fang Jiang; Hong Zou; Yan Qi
Journal:  Onco Targets Ther       Date:  2019-12-10       Impact factor: 4.147

5.  Research hotspots and trends of chordoma: A bibliometric analysis.

Authors:  Jianxuan Gao; Runzhi Huang; Huabin Yin; Dianwen Song; Tong Meng
Journal:  Front Oncol       Date:  2022-09-16       Impact factor: 5.738

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.